Despite two-thirds of incarcerated people having substance use disorder, a new study reveals a lack of therapy options.

Opioid use disorder can be a contributing factor to Americans landing in the nation's prisons and jails, but those inmates typically have no access to medications that could help wean them off the drugs.

Just 44 percent of jails offer incarcerated people with opioid use disorder medications like methadone, buprenorphine or naltrexone to treat addiction, according to a new analysis of 1,028 jails from the National Institute of Drug Abuse.

So finds a new study of over 900 jails nationwide. More than half offered inmates no access to medications against opioid use disorder, said a team of researchers from the University of Chicago. “Offering substance use disorder treatment in justice settings helps to break the debilitating -- and often fatal -- cycle of addiction and incarceration,

Medication for opioid use disorder can save lives. But fewer than half of jails surveyed across the country provide it, a new study found.

Minnesota is seeking a Medicaid waiver to help cover incarcerated people’s health care, including substance use treatment, and has a new workgroup focused on the problem.

Few U.S. jails offer medications for opioid use disorder (MOUD), according to a study published online Sept. 24 in JAMA Network Open. Elizabeth Flanagan Balawajder, M.P.H., from NORC at the University of Chicago,